CMA CPA - Genprex Co Controller

GNPX Stock  USD 1.16  0.10  9.43%   

Insider

CMA CPA is Co Controller of Genprex
Address 3300 Bee Cave Road, Austin, TX, United States, 78746
Phone877-774-4679
Webhttps://www.genprex.com

Genprex Management Efficiency

The company has return on total asset (ROA) of (1.4594) % which means that it has lost $1.4594 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.1888) %, meaning that it created substantial loss on money invested by shareholders. Genprex's management efficiency ratios could be used to measure how well Genprex manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -3.27 in 2024. Return On Capital Employed is likely to drop to -4.4 in 2024. At this time, Genprex's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 49.1 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.7 M in 2024.
Genprex currently holds 3.25 M in liabilities with Debt to Equity (D/E) ratio of 1.11, which is about average as compared to similar companies. Genprex has a current ratio of 10.5, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Genprex's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Richard MDX4 Pharmaceuticals
61
Renato SkerljX4 Pharmaceuticals
N/A
CPA MBAKodiak Sciences
60
Anna MooreTranscode Therapeutics
62
Brian SullivanElevation Oncology
N/A
MBA MBAMereo BioPharma Group
67
RPh PharmDElevation Oncology
40
Valerie MDElevation Oncology
46
Christine CPAMereo BioPharma Group
43
Laxminarayan BhatReviva Pharmaceuticals Holdings
59
Mary DiBiaseX4 Pharmaceuticals
63
Victor MDKodiak Sciences
51
Daren UreHepion Pharmaceuticals
N/A
Frank MDGreenwich Lifesciences
74
Launa AspesletHepion Pharmaceuticals
N/A
Alexandra HughesWilsonMereo BioPharma Group
53
Arthur TaverasX4 Pharmaceuticals
60
Andrew CPACognition Therapeutics
64
Keith MDX4 Pharmaceuticals
53
Todd MDHepion Pharmaceuticals
55
Laxminarayan BhatReviva Pharmaceuticals Holdings
59
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas. Genprex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people. Genprex (GNPX) is traded on NASDAQ Exchange in USA. It is located in 3300 Bee Cave Road, Austin, TX, United States, 78746 and employs 21 people. Genprex is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Genprex Leadership Team

Elected by the shareholders, the Genprex's board of directors comprises two types of representatives: Genprex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genprex. The board's role is to monitor Genprex's management team and ensure that shareholders' interests are well served. Genprex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genprex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ryan MS, CEO, President
CMA CPA, Co Controller
Kalyn Dabbs, Sr Marketing
Suzanne ThorntonJones, Senior Quality
David Schloss, Senior Resources
William Gannon, Member Affairs
Mark MD, Chief Officer
MD FACS, Chairman Board
Catherine Esq, General VP
Thomas Esq, Senior Licensing
CPM EMBA, Chief Officer
John Varner, Chairman, CoFounder

Genprex Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genprex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Genprex Stock Analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.